期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

Efficacy of Auxiliary Therapy with Danggui Buxue Decoction No.1(当归补血汤1号) in Treating Patients of Non-small Cell Lung Cancer at Peri-operational Stage 被引量：6

Efficacy of Auxiliary Therapy with Danggui Buxue Decoction No.1(当归补血汤1号) in Treating Patients of Non-small Cell Lung Cancer at Peri-operational Stage
原文传递
导出
摘要 Objective:To observe the therapeutic efficacy of Danggui Buxue Decoction No.1(当归补血汤1号,DB1) in treating patients of non-small cell lung cancer(NSCLC) at the peri-operational stage and its impact on the patients immune function.Methods:Eighty-two NSCLC patients were randomly assigned to two groups equally,the control group and the test group,they were given conventional treatment,while to the test group, DB1 were given additionally.The observation was conducted by testing the changes of T-lymphocyte subsets,... Objective:To observe the therapeutic efficacy of Danggui Buxue Decoction No.1(当归补血汤1号,DB1) in treating patients of non-small cell lung cancer(NSCLC) at the peri-operational stage and its impact on the patients immune function.Methods:Eighty-two NSCLC patients were randomly assigned to two groups equally,the control group and the test group,they were given conventional treatment,while to the test group, DB1 were given additionally.The observation was conducted by testing the changes of T-lymphocyte subsets,...
作者 杜庆聪 杨奎忠 孙雪飞
机构地区 The Fourteen Area Wujing Shandong Zongdui Hospital
出处 《Chinese Journal of Integrative Medicine》 SCIE CAS 2009年第3期184-188,共5页 中国结合医学杂志（英文版）
关键词 non-small cell lung cancer peri-operational stage immune function Danggui Buxue Decoction No.1 immunotherapy non-small cell lung cancer peri-operational stage immune function Danggui Buxue Decoction No.1 immunotherapy
分类号 R734.2 [医药卫生—肿瘤]
  • 相关文献

参考文献8

  • 1袁顺达,丁建仁,王时晓,崔健,周军庆,楼正龙,喻光懋,王松祥,何斌军.CYFRA21-1在非小细胞肺癌治疗中的监测作用[J].中国现代医学杂志,1997,7(12):9-11. 被引量：3
  • 2OUM Ji-Hyun,HAN Juhyun,MYUNG Heejoon,HLEB Marija,SHARM urendra,PARK Jungchan.Molecular mechanism of NFAT family proteins for differential regulation of the IL-2 and TNF-αpromoters[].Molecules Cells.2002
  • 3Pujol JL,Grenier J,Daur■s JP,Daver A,Pujol H,Michel FB.Serum fragment of cytokeration subunit 19 measured by CYFRA21-1.Immunoradiometric assay as a marker of lung cancer[].Cancer Research.1993
  • 4Rschowitz EA,Foody T,et al.Immunization of NSCLC patients with antigen-pulsed immature autologous dendrie cells[].Lung Cancer.2007
  • 5ABIKO T,KAWAMURAM,IZUMI Y,etal.Prediction ofanti-tumour effectofthermochemotherapywith in vitrothermochemosen-sitivity testing for non-small cell lung cancer[].International Journal of Hyperthermia.2007
  • 6Francois Ghiringhelli, C&eacute,dric M&eacute,nard, Francois Martin, Laurence Zitvogel<.The role of regulatory T cells in the control of natural killer cells: relevance during tumor progression[].Immunological Reviews.2006
  • 7Schiller JH,Morgan Ihrig C,Levitt MC.Concomitant administration of interleukin-2 plus tumor necrosis factorαin advanced non-small-cell lung cancer[].American Journal of Clinical Oncology.1995
  • 8van der,Gaast,A.,Schoenmakers,C.H.,Kok,T.C.Evaluation of a new tumour marker in patients with non-small-cell lung cancer: Cyfra 21.1[].British Journal of Cancer.1994

共引文献2

同被引文献120

引证文献6

二级引证文献103

Chinese Journal of Integrative Medicine
2009年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部